about
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients ...
Read More
6.31
-0.23
(-3.52%)
301.4K
XNAS Volume
XNAS 03 Mar, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Cingulate Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..